Cargando…
Computational Exploration of Potential CFTR Binding Sites for Type I Corrector Drugs
[Image: see text] Cystic fibrosis (CF) is a recessive genetic disease that is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The recent development of a class of drugs called “correctors”, which repair the structure and function of mutant CFTR, has gre...
Autores principales: | Lester, Anna, Sandman, Madeline, Herring, Caitlin, Girard, Christian, Dixon, Brandon, Ramsdell, Havanna, Reber, Callista, Poulos, Jack, Mitchell, Alexis, Spinney, Allison, Henager, Marissa E., Evans, Claudia N., Turlington, Mark, Johnson, Quentin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433520/ https://www.ncbi.nlm.nih.gov/pubmed/37437308 http://dx.doi.org/10.1021/acs.biochem.3c00165 |
Ejemplares similares
-
Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012) -
Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors
por: Saint-Criq, Vinciane, et al.
Publicado: (2021) -
Bithiazole Correctors Rescue CFTR Mutants by Two Different
Mechanisms
por: Loo, Tip W., et al.
Publicado: (2013) -
Correctors modify the bicarbonate permeability of F508del-CFTR
por: Fiore, Michele, et al.
Publicado: (2020) -
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
por: Spanò, Virginia, et al.
Publicado: (2021)